Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
Trial ID or NCT#
NCT00285727
Status
NOT RECRUITING
Purpose
This is an 8 week study for patients who are currently taking antidepressant medication but not fully responding. Ropinirole CR would be taken in conjunction with current antidepressant medication. Patients come into the clinic once a week when starting on the medication and then once every other week for the remainder of the 8 weeks.
Official Title
Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
Eligibility Criteria
Ages Eligible for Study: 18 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Age 18 to 65 years old - Currently experiencing major depression - On at least an adequate dose of fluoxetine, paroxetine, sertraline, citalopram, escitalopram, venlafaxine, bupropion, mirtazapine or duloxetine for at least 6 weeks (monotherapy).
Exclusion Criteria:
- 1. Pregnant females or females of child bearing years not using adequate birth control in the opinion of the investigators - Known sensitivity to ropinirole - Significant medical conditions that would preclude safe participation in the study in the opinion of the investigators. - Significant abnormalities observed in screening laboratory evaluation
Investigator(s)
Charles DeBattista
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
Contact us to find out if this trial is right for you.
Contact
Jessica Hawkins
6507238323
View on ClinicalTrials.gov
